Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center

Background. Esophageal cancer (EC) is one of the most aggressive malignancies of the gastrointestinal tract. Chemoradiation therapy is the standard of care for locally advanced EC. The purpose of the study was to evaluate the efficacy of chemoradiation therapy given alone and in combination with surgery in patients with thoracic esophageal cancer. Material and Methods. From January 1, 2012 to December 31, 2021, a total of 940 patients with thoracic esophageal cancer were registered in the regional cancer registry, of which 178 patients were selected for concurrent chemoradiotherapy (CRT) at clinical stages I-III. Thirty seven thoracic esophageal cancer patients who received CRT and required treatment interruption due to complications were not included in our analysis. The final analysis included 141 patients.